Víctor Moreno

机构：Empresa Municipal de Transportes de Madrid, Hospital Universitario Fundación Jiménez Díaz · ORCID：0000-0001-6099-4236

发表论文 597 篇 · 总被引 14362 次 · h-index 54

代表论文

• Cibisatamab and FAP-4-1BBL in microsatellite-stable colorectal cancer: a phase 1b trial (2026 · Nature Medicine · 被引 6)
• Amivantamab Monotherapy in Chemorefractory RAS / BRAF Wild-Type Metastatic Colorectal Cancer: Results From OrigAMI-1, an Open-Label, Phase Ib/II Study (2026 · Journal of Clinical Oncology · 被引 5)
• Phase Ib trial of SL-172154, a bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, in combination with mirvetuximab soravtansine or pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer (2026 · British Journal of Cancer · 被引 2)
• First-in-human study of lomvastomig, a PD-1-TIM-3 bispecific antibody, in patients with advanced and/or metastatic solid tumors (2026 · Journal for ImmunoTherapy of Cancer · 被引 1)
• Supplementary Data1 from A Phase Ib/IIa Study of Fostrox in Combination with Lenvatinib as Second-line Therapy in Patients with Advanced Hepatocellular Carcinoma (2026)
• Data from A Phase Ib/IIa Study of Fostrox in Combination with Lenvatinib as Second-line Therapy in Patients with Advanced Hepatocellular Carcinoma (2026)